VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NATRNature's Sunshine Products, Inc.
$21.02$370M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksNATRFinancials

Nature's Sunshine Products, Inc. (NATR) Financials

30Y historyFree accessUpdated daily

Revenue growth remains inconsistent with an 8.5% year-over-year increase in 2026Q1, while operating margins struggle to scale beyond a 7.8% peak due to heavy SG&A absorption.

NATR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue489.79M480.14M454.36M445.32M421.91M444.08M385.2M362.21M364.81M342.03M341.16M324.7M366.37M378.1M367.47M367.81M349.92M343.02M381.3M366.65M362.22M351.68M331.06M297.26M298.73M318.72M314.82M289.2M296.1M280.9M249M
Revenue Growth %7.26%5.67%2.03%5.55%-4.99%15.29%6.35%-0.71%6.66%0.26%5.07%-11.37%-3.1%2.89%-0.09%5.11%2.01%-10.04%4%1.22%3%6.23%11.37%-0.49%-6.27%1.24%8.86%-2.33%5.41%12.81%21.11%
Cost of Goods Sold136.91M132.42M129.68M124.19M122.15M115.47M101.28M93.94M95.69M91.04M90.94M85.34M91.58M94.81M93.32M69.41M69.04M68.8M71.87M71M68.75M67.59M62.69M51.93M53.32M57.66M48.52M45.1M47.4M47.3M41.5M
COGS % of Revenue-27.58%28.54%27.89%28.95%26%26.29%25.93%26.23%26.62%26.66%26.28%25%25.08%25.4%18.87%19.73%20.06%18.85%19.36%18.98%19.22%18.94%17.47%17.85%18.09%15.41%15.59%16.01%16.84%16.67%
Gross Profit352.88M347.72M324.69M321.13M299.76M328.62M283.93M268.27M269.12M250.99M250.22M239.36M274.78M283.28M274.14M298.4M280.88M274.22M309.43M295.65M293.48M284.09M268.37M245.34M245.42M261.06M266.3M244.1M248.7M233.6M207.5M
Gross Margin %72.05%72.42%71.46%72.11%71.05%74%73.71%74.07%73.77%73.38%73.34%73.72%75%74.92%74.6%81.13%80.27%79.94%81.15%80.64%81.02%80.78%81.06%82.53%82.15%81.91%84.59%84.41%83.99%83.16%83.33%
Gross Profit Growth %-7.09%1.11%7.13%-8.78%15.74%5.84%-0.31%7.22%0.31%4.54%-12.89%-3%3.33%-8.13%6.24%2.43%-11.38%4.66%0.74%3.3%5.86%9.39%-0.03%-5.99%-1.97%9.09%-1.85%6.46%12.58%21.63%
Operating Expenses324.76M322.98M304.59M302.38M283.5M293.95M262.45M252.15M263.77M249.6M240.18M225.49M255.74M259.23M240.13M278.24M269.62M263.45M303.83M292.59M285.47M272.51M246.72M237.63M233.75M237.16M239.67M217M212.6M202.6M181.1M
OpEx % of Revenue-67.27%67.04%67.9%67.19%66.19%68.13%69.61%72.3%72.98%70.4%69.44%69.8%68.56%65.35%75.65%77.05%76.8%79.68%79.8%78.81%77.49%74.52%79.94%78.25%74.41%76.13%75.03%71.8%72.13%72.73%
Selling, General & Admin324.76M322.98M304.59M302.38M283.5M293.95M262.45M252.15M263.77M249.6M240.18M225.49M255.74M259.23M240.13M278.24M269.62M263.45M303.83M148.71M139.65M128.38M246.72M198.57M233.75M237.16M232.74M210.9M207.8M198.3M177.7M
SG&A % of Revenue-67.27%67.04%67.9%67.19%66.19%68.13%69.61%72.3%72.98%70.4%69.44%69.8%68.56%65.35%75.65%77.05%76.8%79.68%40.56%38.55%36.5%74.52%66.8%78.25%74.41%73.93%72.93%70.18%70.59%71.37%
Research & Development001.7M01.5M0002.8M3.4M3.2M2.8M2.5M2M1.46M0000000000000000
R&D % of Revenue--0.37%-0.36%---0.77%0.99%0.94%0.86%0.68%0.53%0.4%----------------
Other Operating Expenses00-1.7M0-1.5M000-2.15M0-773K0-34K000000143.88M145.83M144.13M039.06M006.93M6.1M4.8M4.3M3.4M
Operating Income28.12M24.74M20.09M18.75M16.26M34.67M21.48M16.13M5.35M1.39M10.04M13.87M19.05M24.06M34.02M20.16M11.26M10.77M5.6M3.06M8.01M11.59M21.65M7.71M11.67M23.9M26.63M27.1M36.1M31M26.4M
Operating Margin %5.74%5.15%4.42%4.21%3.85%7.81%5.58%4.45%1.47%0.41%2.94%4.27%5.2%6.36%9.26%5.48%3.22%3.14%1.47%0.83%2.21%3.29%6.54%2.59%3.91%7.5%8.46%9.37%12.19%11.04%10.6%
Operating Income Growth %-23.13%7.18%15.32%-53.11%61.39%33.22%201.35%285.8%-86.18%-27.63%-27.17%-20.82%-29.28%68.69%79.04%4.61%92.34%82.88%-61.76%-30.9%-46.5%181%-33.96%-51.18%-10.25%-1.74%-24.93%16.45%17.42%50%
EBITDA41.69M38.59M34.31M30.57M31.94M45.83M32.23M26.72M15.25M10.02M14.85M18.4M23.46M28.52M38.09M24.53M15.52M15.27M11.04M-3.35M1.78M5.63M27.38M14.09M19.97M30.73M33.55M33.2M40.9M35.3M29.8M
EBITDA Margin %8.51%8.04%7.55%6.86%7.57%10.32%8.37%7.38%4.18%2.93%4.35%5.67%6.4%7.54%10.37%6.67%4.43%4.45%2.89%-0.91%0.49%1.6%8.27%4.74%6.68%9.64%10.66%11.48%13.81%12.57%11.97%
EBITDA Growth %15.15%12.45%12.27%-4.3%-30.31%42.23%20.58%75.23%52.19%-32.5%-19.3%-21.57%-17.76%-25.12%55.31%58.07%1.63%38.36%429.6%-287.98%-68.34%-79.45%94.28%-29.41%-35.02%-8.43%1.07%-18.83%15.86%18.46%41.23%
D&A (Non-Cash Add-back)13.57M13.84M14.22M11.82M15.68M11.16M10.74M10.6M9.9M8.63M4.81M4.53M4.41M4.47M4.08M4.36M4.25M4.5M5.44M-6.41M-6.22M-5.96M5.73M6.39M8.3M6.83M6.93M6.1M4.8M4.3M3.4M
EBIT32.3M29.91M18.57M20.27M15.46M32.07M22.92M15.69M3.59M1.39M10.04M17.18M21.25M25.81M35.62M22.1M13.99M14.45M6.52M4.53M9.24M12.15M21.65M7.71M11.67M23.9M26.63M27.1M36.1M31M26.4M
Net Interest Income303K547K31K483K-126K216K69K219K-387K-145K575K1.36M-187K605K1.28M1.38M270K1.32M1.78M1.34M710K91K464K1.25M1.05M1.66M1.92M000-100K
Interest Income389K645K177K552K123K466K171K262K0144K591K1.49M0836K1.46M1.47M270K1.41M1.83M1.41M1.32M821K568K1.52M1.09M1.67M1.94M0000
Interest Expense86K98K146K69K249K250K102K43K387K289K16K130K187K231K178K89K0124K52K69K609K730K104K268K39K4K20K000100K
Other Income/Expense2.74M5.07M-1.67M1.45M-1.04M-2.85M1.34M-483K-2.15M1.83M-773K-592K-34K1.6M1.48M1.85M2.73M1.89M870K1.4M624K-162K1.31M-474K-972K1.44M1.29M1.9M2.3M2.2M1.4M
Pretax Income30.86M29.81M18.43M20.2M15.21M31.82M22.82M15.64M3.2M3.22M9.27M13.28M19.01M25.65M35.5M22.01M13.99M14.32M6.47M4.46M8.63M11.42M22.96M7.23M10.7M25.33M27.92M29M38.4M33.2M27.8M
Pretax Margin %6.3%6.21%4.06%4.54%3.61%7.17%5.92%4.32%0.88%0.94%2.72%4.09%5.19%6.78%9.66%5.98%4%4.18%1.7%1.22%2.38%3.25%6.94%2.43%3.58%7.95%8.87%10.03%12.97%11.82%11.16%
Income Tax10.17M9.36M10.53M3.79M14.66M1.61M-137K8.71M4.4M17.04M8.59M1.74M-743K8.04M10.12M4.41M5.52M8.21M8.31M12.7M12.19M7.92M5.88M2.13M3.63M8.67M10.79M11.2M15.1M13.1M11M
Effective Tax Rate %32.97%31.4%57.17%18.74%96.39%5.08%-0.6%55.7%137.56%528.83%92.72%13.1%-3.91%31.36%28.5%20.04%39.46%57.31%128.42%284.48%141.31%69.33%25.62%29.49%33.96%34.24%38.64%38.62%39.32%39.46%39.57%
Net Income19.89M19.52M7.7M15.08M-390K28.85M21.34M6.76M-854K-12.94M2.14M14.69M10.02M17.61M25.38M17.6M-1.23M6.12M-1.84M-8.24M-3.56M3.5M17.08M5.1M7.06M16.66M17.13M17.8M23.3M20.1M16.8M
Net Margin %4.06%4.07%1.69%3.39%-0.09%6.5%5.54%1.87%-0.23%-3.78%0.63%4.52%2.73%4.66%6.91%4.79%-0.35%1.78%-0.48%-2.25%-0.98%1%5.16%1.72%2.36%5.23%5.44%6.15%7.87%7.16%6.75%
Net Income Growth %96.52%153.65%-48.95%3965.64%-101.35%35.23%215.4%892.15%93.4%-705.05%-85.44%46.59%-43.1%-30.62%44.2%1527.49%-120.16%432.7%77.69%-131.05%-201.74%-79.48%234.93%-27.82%-57.6%-2.76%-3.76%-23.61%15.92%19.64%41.18%
Net Income (Continuing)20.68M20.45M7.89M16.42M550K30.21M22.96M6.93M-1.2M-13.82M675K11.54M19.76M17.65M25.38M17.6M8.47M6.55M-1.84M-8.24M-3.56M3.5M17.08M5.1M7.06M16.66M17.13M17.8M23.3M20.1M16.8M
Discontinued Operations000000000002.12M0000000000000000000
Minority Interest005.68M5.48M4.14M3.2M1.85M227K63K411K1.29M2.75M3.78M000000000000000000
EPS (Diluted)1.111.060.400.77-0.021.421.070.34-0.04-0.690.110.770.561.071.591.12-0.080.39-0.12-0.53-0.230.231.100.360.430.991.021.001.251.060.86
EPS Growth %106.38%165%-48.05%3950%-101.41%32.71%214.71%860.63%93.52%-727.27%-85.71%37.5%-47.66%-32.7%41.96%1517.72%-120.26%425%77.36%-130.43%-200%-79.09%205.56%-16.28%-56.57%-2.94%2%-20%17.92%23.26%36.51%
EPS (Basic)-1.080.410.79-0.021.451.090.35-0.04-0.690.110.790.581.101.621.13-0.080.39-0.12-0.53-0.230.231.140.360.451.021.021.011.271.080.86
Diluted Shares Outstanding17.93M18.47M18.62M19.47M19.33M20.33M19.97M19.66M19.12M18.88M19.06M19.18M17.64M16.39M15.99M15.7M15.61M15.51M15.51M15.49M15.34M15.52M15.48M14.16M16.43M16.83M16.8M17.8M18.64M18.96M19.68M
Basic Shares Outstanding17.52M18M18.62M19.07M19.33M19.86M19.54M19.31M19.12M18.76M18.73M18.66M17.11M16M15.65M15.55M15.52M15.51M15.51M15.49M15.34M15.21M14.92M14.16M15.7M16.33M16.8M17.62M18.35M18.61M19.68M
Dividend Payout Ratio-----68.82%----351.05%51%351.61%172.75%9.26%--12.69%---87.13%17.57%37.09%29.88%13.03%13.12%12.92%10.73%12.44%14.88%

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Regulatory and recruitment churn

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Growth Exhibits Volatile Recovery

According to the most recent quarterly filings, Nature's Sunshine reported revenue of $122.9 million, reflecting an 8.5% year-over-year growth rate that suggests a modest recovery from the contraction observed in early 2024, though top-line performance remains inconsistent across the trailing ten-quarter period.

The revenue trajectory appears sensitive to the cyclical nature of consultant recruitment and international market conditions. While the recent 8.5% growth indicates some success in stabilizing the sales funnel, investors should monitor whether this is a sustainable trend or merely a temporary rebound from prior-year weakness.

Structural Gross Margin Stability Persists

As reported in financial statements, the company maintains a robust gross margin profile, consistently hovering around 72% over the last ten quarters, which underscores the inherent pricing power of its specialized botanical product portfolio despite broader inflationary pressures impacting the direct-selling industry's cost of goods sold.

This high gross margin is a hallmark of the company's manufacturing-led model, providing a significant buffer against variable cost fluctuations. However, the inability to translate this high gross profitability into meaningful operating margin expansion suggests that the cost of maintaining the consultant network remains a structural drag.

Operating Leverage Remains Constrained

Based on the provided income statement data, operating margins have struggled to scale, fluctuating between 3.7% and 7.8% over the last ten quarters, indicating that SG&A expenses continue to absorb the vast majority of gross profit gains generated by the company's core nutritional supplement business.

The lack of significant operating leverage suggests that the company's current digital transformation and rebranding efforts have yet to yield the expected efficiency gains. Investors should investigate whether the high SG&A burden is a permanent feature of the direct-selling model or a temporary investment phase.

Earnings Quality Impacted by Volatility

Analysis of the company's historical income statements reveals significant quarterly earnings volatility, with net income margins ranging from a negative 0.3% in 2024Q4 to a high of 8.2% in 2023Q4, largely driven by non-operating items and fluctuations in stock-based compensation expenses.

The inconsistency in net income suggests that reported EPS may not always reflect the underlying operational health of the business. The periodic spikes in stock-based compensation and tax-related adjustments warrant further investigation to determine the true normalized earnings power of the organization.

Sustainability of Consultant-Led Revenue Model

Data from recent filings indicates that the company's reliance on a high-touch consultant network creates a persistent risk, as evidenced by the 2024Q2 revenue decline, which highlights the potential for rapid sales erosion if consultant engagement levels fail to meet the company's internal growth targets.

Short-term revenue gains may mask underlying churn within the consultant base, which is the primary engine of the company's sales. If the shift toward digital channels fails to attract new customers, the company may face a structural decline that current gross margin levels cannot offset.

NATR — Frequently Asked Questions

Quick answers to the most common questions about buying NATR stock.

What was Nature's Sunshine Products, Inc.'s (NATR) revenue in 2025?

For fiscal year 2025, Nature's Sunshine Products, Inc. (NATR) reported total revenue of $480.1M. This represents a 92.8% increase compared to $249.0M in 1996.

Is Nature's Sunshine Products, Inc. (NATR) profitable?

Nature's Sunshine Products, Inc. (NATR) is profitable, generating $19.5M in net income for the fiscal year ending 2025 with a net profit margin of 4.1%.

What is Nature's Sunshine Products, Inc.'s operating profit margin?

Nature's Sunshine Products, Inc. (NATR) reported an operating income of $24.7M, resulting in an operating profit margin of 5.2%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Nature's Sunshine Products, Inc.'s gross profit and gross margin?

Nature's Sunshine Products, Inc. (NATR) generated $347.7M in gross profit for the year, representing a gross profit margin of 72.4%. This demonstrates the company's core pricing power and production efficiency.